Study of in vitro biological activity of thiazoles on Leishmania (Leishmania) infantum.

[1]  J. Suchodolski,et al.  Evaluation of nephrotoxicity and ototoxicity of aminosidine (paromomycin)-allopurinol combination in dogs with leishmaniosis due to Leishmania infantum: A randomized, blinded, controlled study. , 2019, Experimental parasitology.

[2]  S. Sundar,et al.  Leishmania donovani-Induced Increase in Macrophage Bcl-2 Favors Parasite Survival , 2016, Front. Immunol..

[3]  Y. Pérez-Pertejo,et al.  Current status on prevention and treatment of canine leishmaniasis. , 2016, Veterinary parasitology.

[4]  R. Brun,et al.  Synthesis of novel amide and urea derivatives of thiazol-2-ethylamines and their activity against Trypanosoma brucei rhodesiense. , 2016, Bioorganic & medicinal chemistry.

[5]  D. Sereno,et al.  Escaping Deleterious Immune Response in Their Hosts: Lessons from Trypanosomatids , 2016, Front. Immunol..

[6]  J. Estaquier,et al.  Regulation of immunity during visceral Leishmania infection , 2016, Parasites & Vectors.

[7]  L. David,et al.  Allopurinol Resistance in Leishmania infantum from Dogs with Disease Relapse , 2016, PLoS neglected tropical diseases.

[8]  L. Alves,et al.  Transmission routes of visceral leishmaniasis in mammals , 2015 .

[9]  R. S. Ferreira,et al.  2-Pyridyl thiazoles as novel anti-Trypanosoma cruzi agents: structural design, synthesis and pharmacological evaluation. , 2014, European journal of medicinal chemistry.

[10]  R. Moo-Puc,et al.  2-acylamino-5-nitro-1,3-thiazoles: preparation and in vitro bioevaluation against four neglected protozoan parasites. , 2014, Bioorganic & medicinal chemistry.

[11]  R. S. Ferreira,et al.  Structural Design, Synthesis and Structure–Activity Relationships of Thiazolidinones with Enhanced Anti‐Trypanosoma cruzi Activity , 2014, ChemMedChem.

[12]  J. Barnes,et al.  The Malnutrition-Related Increase in Early Visceralization of Leishmania donovani Is Associated with a Reduced Number of Lymph Node Phagocytes and Altered Conduit System Flow , 2013, PLoS neglected tropical diseases.

[13]  A. Cruz,et al.  Synthesis, Cytotoxicity and In Vitro Antileishmanial Activity of Naphthothiazoles , 2013, Chemical biology & drug design.

[14]  R. Lesyk,et al.  Synthesis and antitrypanosomal activity of new 6,6,7-trisubstituted thiopyrano[2,3-d][1,3]thiazoles. , 2012, Bioorganic & medicinal chemistry letters.

[15]  C. Galiana-Roselló,et al.  Nuclease activity and ultrastructural effects of new sulfonamides with anti-leishmanial and trypanocidal activities. , 2012, Parasitology international.

[16]  V. Kojić,et al.  Synthesis and in vitro antitumour screening of 2-(β-D-xylofuranosyl)thiazole-4-carboxamide and two novel tiazofurin analogues with substituted tetrahydrofurodioxol moiety as a sugar mimic. , 2012, Bioorganic & medicinal chemistry letters.

[17]  Rajni Singh,et al.  Developments in Diagnosis and Antileishmanial Drugs , 2012, Interdisciplinary perspectives on infectious diseases.

[18]  C. Barbiéri,et al.  In Vitro and In Vivo Activity of a Palladacycle Complex on Leishmania (Leishmania) amazonensis , 2012, PLoS neglected tropical diseases.

[19]  T. Naucke,et al.  First report of venereal and vertical transmission of canine leishmaniosis from naturally infected dogs in Germany , 2012, Parasites & Vectors.

[20]  Reddanna Pallu,et al.  Synthesis of novel 2-mercapto benzothiazole and 1,2,3-triazole based bis-heterocycles: their anti-inflammatory and anti-nociceptive activities. , 2012, European journal of medicinal chemistry.

[21]  Changlin Zhou,et al.  Synthesis and evaluation of anti-tubercular and antibacterial activities of new 4-(2,6-dichlorobenzyloxy)phenyl thiazole, oxazole and imidazole derivatives. Part 2. , 2012, European journal of medicinal chemistry.

[22]  N. Fasel,et al.  Apoptotic markers in protozoan parasites , 2010, Parasites & Vectors.

[23]  Solomon Nwaka,et al.  Advancing Drug Innovation for Neglected Diseases—Criteria for Lead Progression , 2009, PLoS neglected tropical diseases.

[24]  E. Hernández-Núñez,et al.  Nitazoxanide, tizoxanide and a new analogue [4-nitro-N-(5-nitro-1,3-thiazol-2-yl)benzamide; NTB] inhibit the growth of kinetoplastid parasites (Trypanosoma cruzi and Leishmania mexicana) in vitro. , 2009, The Journal of antimicrobial chemotherapy.

[25]  F. L. Silva,et al.  Venereal transmission of canine visceral leishmaniasis. , 2009, Veterinary parasitology.

[26]  C. Costa.  Characterization and speculations on the urbanization of visceral leishmaniasis in Brazil. , 2008, Cadernos de saude publica.

[27]  W. de Souza,et al.  Ultrastructural alterations in organelles of parasitic protozoa induced by different classes of metabolic inhibitors. , 2008, Current pharmaceutical design.

[28]  A. L. Abreu-Silva,et al.  Animal reservoirs for visceral leishmaniasis in densely populated urban areas. , 2008, Journal of infection in developing countries.

[29]  M. Olivier,et al.  Role of Host Protein Tyrosine Phosphatase SHP-1 in Leishmania donovani-Induced Inhibition of Nitric Oxide Production , 2006, Infection and Immunity.

[30]  R. Pink,et al.  Opportunities and Challenges in Antiparasitic Drug Discovery , 2005, Nature Reviews Drug Discovery.

[31]  A. Henriques-Pons,et al.  Effect of the lysophospholipid analogues edelfosine, ilmofosine and miltefosine against Leishmania amazonensis. , 2004, The Journal of antimicrobial chemotherapy.

[32]  James Alexander,et al.  Cysteine peptidases as virulence factors of Leishmania. , 2004, Current opinion in microbiology.

[33]  N. Bharti,et al.  synthesis, characterization and in vitro antiamoebic activity of 5-nitrothiophene-2-carboxaldehyde thiosemicarbazones and their Palladium (II) and Ruthenium (II) complexes. , 2004, European journal of medicinal chemistry.

[34]  W. de Souza,et al.  Megasome biogenesis in Leishmania amazonensis : a morphometric and cytochemical study , 2001, Parasitology Research.

[35]  M. Bogyo,et al.  Cysteine protease inhibitors as chemotherapy: lessons from a parasite target. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[36]  P. Debré,et al.  Interleukin‐10 and interleukin‐4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation , 1997, European journal of immunology.

[37]  C. Nathan,et al.  Nitric oxide and macrophage function. , 1997, Annual review of immunology.

[38]  J. Shaw,et al.  Taxonomy of the genus Leishmania: present and future trends and their implications. , 1994, Memorias do Instituto Oswaldo Cruz.

[39]  A. Frasch,et al.  Identification of a Trypanosoma cruzi antigen that is shed during the acute phase of Chagas' disease. , 1989, Molecular and biochemical parasitology.